Connection

Solange Peters to Immunotherapy

Back to Details
This is a "connection" page, showing publications Solange Peters has written about Immunotherapy.
Solange Peters
Connection Strength
0.652
Immunotherapy
  1. Characterisation of rare haematological immune-related toxicities. Lancet Haematol. 2019 01; 6(1):e10-e11.
    View in: PubMed
    Score: 0.284
  2. [The new management options for lung cancer in the immunotherapy era]. Rev Med Suisse. 2019 May 15; 15(651):1032-1037.
    View in: PubMed
    Score: 0.073
  3. [Oncology, what's new in 2018]. Rev Med Suisse. 2019 Jan 09; 15(N° 632-633):78-81.
    View in: PubMed
    Score: 0.071
  4. New therapeutic perspectives to manage refractory immune checkpoint-related toxicities. Lancet Oncol. 2019 01; 20(1):e54-e64.
    View in: PubMed
    Score: 0.071
  5. Genomic Features of Response to Combination Immunotherapy in Lung Cancer. Cancer Cell. 2018 05 14; 33(5):791-793.
    View in: PubMed
    Score: 0.068
  6. Immunotherapy for Unresectable Stage III Non-Small-Cell Lung Cancer. N Engl J Med. 2017 11 16; 377(20):1986-1988.
    View in: PubMed
    Score: 0.066
  7. Brain metastases. Nat Rev Dis Primers. 2019 01 17; 5(1):5.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.